Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Tyra Biosciences, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 4 Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 500 shares @ $16.13, valued at $8.1k
Sold 1,900 shares @ $16.0337, valued at $30.5k
Exercised 500 options to buy @ $0.61, valued at $305
Exercised 1,900 options to buy @ $0.61, valued at $1.2k
07/12/2023 4 Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 1,202 shares @ $16.0069, valued at $19.2k
Sold 500 shares @ $16.019, valued at $8k
Exercised 201 shares @ $0.61, valued at $122.6
Sold 201 shares @ $16.2304, valued at $3.3k
Exercised 1,202 options to buy @ $0.61, valued at $733.2
Exercised 500 options to buy @ $0.61, valued at $305
Exercised 201 options to buy @ $0.61, valued at $122.6
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2023 4 Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 10,862 shares @ $16.4916, valued at $179.1k
Sold 6,370 shares @ $17.236, valued at $109.8k
Sold 7,893 shares @ $16.73, valued at $132k
Sold 8,135 shares @ $17.0897, valued at $139k
Sold 13,524 shares @ $16.906, valued at $228.6k
Exercised 17,232 options to buy @ $0.61, valued at $10.5k
Exercised 16,028 options to buy @ $0.61, valued at $9.8k
Exercised 13,524 options to buy @ $0.61, valued at $8.2k
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/15/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 7,927 shares @ $16.0048, valued at $126.9k
Sold 12,773 shares @ $16.1275, valued at $206k
Exercised 7,927 options to buy @ $2.25, valued at $17.8k
Exercised 12,773 options to buy @ $2.25, valued at $28.7k
06/15/2023 4 Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 5,628 shares @ $16.0144, valued at $90.1k
Sold 120 shares @ $16.45, valued at $2k
Sold 12,592 shares @ $16.1453, valued at $203.3k
Exercised 5,628 options to buy @ $0.61, valued at $3.4k
Exercised 120 options to buy @ $0.61, valued at $73.2
Exercised 12,592 options to buy @ $0.61, valued at $7.7k
06/02/2023 4 KAPLAN GILLA (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 Verjee Rehan (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 CHEN ISAN (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 Simson Jake (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 Subramony Siddarth (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 MORE ROBERT J (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
06/02/2023 4 Kjellson Nina S (Director) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 14,500 options to buy @ $14.47, valued at $209.8k
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/17/2023 ARS Form ARS - Annual Report to Security Holders:
04/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 2,000 shares @ $16.126, valued at $32.3k
Exercised 2,000 options to buy @ $2.25, valued at $4.5k
04/03/2023 4 Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 2,000 shares @ $16.0075, valued at $32k
Sold 400 shares @ $16.0006, valued at $6.4k
Sold 2,000 shares @ $16.1569, valued at $32.3k
Exercised 2,000 options to buy @ $0.61, valued at $1.2k
Exercised 400 options to buy @ $0.61, valued at $244
Exercised 2,000 options to buy @ $0.61, valued at $1.2k
03/31/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 1,420 shares @ $16.1835, valued at $23k
Sold 2,407 shares @ $16.0166, valued at $38.6k
Sold 500 shares @ $16.046, valued at $8k
Exercised 1,420 options to buy @ $2.25, valued at $3.2k
Exercised 2,407 options to buy @ $2.25, valued at $5.4k
Exercised 500 options to buy @ $2.25, valued at $1.1k
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy